Longitudinal Effects of Nucleos(t)ide Analogue Therapy in Chronic Hepatitis B Patients and the Utility of Non-invasive Fibrosis Markers During Treatment: A single-center experience for up to 17 years

BACKGROUND: Fibrosis regression has been associated with nucleoside analog (NA) treatment in chronic hepatitis B (CHB) patients. Although non-invasive fibrosis markers have been evaluated in CHB, their utility for monitoring on-treatment histologic regression has not been evaluated. AIMS: To charact...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Antiviral Res
Autors principals: Surana, Pallavi, Kapuria, Devika, Broadwell, Carly, Wright, Elizabeth C., Takyar, Varun, Kleiner, David E., Ghany, Marc G., Ben-Yakov, Gil, Heller, Theo, Liang, T. Jake, Koh, Christopher
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6620142/
https://ncbi.nlm.nih.gov/pubmed/31125632
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2019.05.007
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars